where the groups are as defined in the description here below, the racemic mixtures, their individual enantiomers, their individual diastereoisomers, their mixtures, and their pharmaceutically acceptable salts. Said compounds are topoisomerase I inhibitors.
摘要:
The use of esters of L-carnitine and alkanoyl L-carnitines as cationic lipids for the intracellular delivery of pharmacologically active compounds is described. The esters according to the invention have general formula (II) wherein the R groups are as defined in the description.
摘要:
Esters of L-carnitine and alkanoyl L-carnitines are described which can be used as cationic lipids for the intracellular delivery of pharmacologically active compounds.
摘要:
The use of esters of L-carnitine and alkanoyl L-carnitines as cationic lipids for the intracellular delivery of pharmacologically active compounds is described. The esters according to the invention have general formula (II) wherein the R groups are as defined in the description.